申请人:Schering Corporation
公开号:US05939431A1
公开(公告)日:1999-08-17
Compounds of formula ##STR1## or pharmaceutically acceptable salts thereof, wherein E, Q, T, U, V, L, Z, X, W, M, Y and Y' are as set forth herein, are described. These compounds are useful as agents in the treatment of allergy, inflammation, autoimmune diseases, B-cell lymphomas, tumors, and the after effects of bone marrow transplantation.
公式##STR1##的化合物或其药用盐,其中E、Q、T、U、V、L、Z、X、W、M、Y和Y'如本文所述,被描述。这些化合物在治疗过敏、炎症、自身免疫疾病、B细胞淋巴瘤、肿瘤以及骨髓移植后的后遗症中作为药剂是有用的。